tirzepatide vs semaglutide benefits risks caused roughly half as many patients to stop treatment because of gastrointestinal side effects as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide Semaglutide and tirzepatide significantly improve

Errichi, S., Bottari, A., Belcaro, G., Cesarone, M

Cost-benefit at scale: If millions use retatrutide for years, do the cardiovascular and diabetes prevention benefits outweigh the side effect burden and $15,00018,000 annual cost

Action of glucagon-like peptide 1 and glucose levels on corticotropin-releasing factor and vasopressin gene expression in rat hypothalamic 4B cells

Understanding your dosing schedule is the first step toward optimizing results with personalized GLP-1 therapy

Individuals can find freedom from heroin use disorder

Ginsenosides: a potential natural medicine to protect the lungs from lung cancer and inflammatory lung disease